Gene signature of early hypoxia to predict patient survival

Details Gene signature of early hypoxia to predict patient survival Gene signature of early hypoxia to predict patient survival

2011-06-14

2011-06-14

Goddard, Laura B (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

07960114

ABSTRACT:
The present invention provides methods and compositions for predicting patient responses to cancer treatment using hypoxia gene signatures. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.

REFERENCES:
patent: 7421417 (2008-09-01), Mangasarian et al.
patent: 2007/0021918 (2007-01-01), Natsoulis et al.
patent: 2006/119593 (2006-11-01), None
patent: 2008/037700 (2008-04-01), None
patent: 2008/094678 (2008-08-01), None
NCBI, “UniGene entry Hs.596783 has been retired,” printed Mar. 2010, one page.
Sorlie et al (PNAS, 2001, 98:10869-10874).
Chi et al (PLoS medicine, Mar. 2006, 3:395-409).
Sorlie et al, 2001, Supplemental Figure 5.
Sorlie et al, 2001, Supplemental Figure 7.
Sorlie et al, 2001, Supplemental Figure 8.
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Bi, J., Bennett, K., Embrechts, M., Breneman, C. & Song, M. “Dimensionality reduction via sparse support vector machines” Journal of Machine Learning Research 3, 1229-1243 (2003).
David G. Kleinbaum and J. Klein, “Statistics for Biology and Health—A Self-Learning Text”, Springer, Second Edition, 2003; pp. 45-82.
Span et al., “Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: Association with treatment outcome”, British Journal of Cancer, vol. 89, No. 2, Jul. 21, 2003, pp, 271-276.
Trastour et al., “HIF-1 alpha and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome”, International Journal of Cancer, John Wiley & Sons, Inc, US, Switzerland, Germany, vol. 120, No. 7, Apr. 1, 2007, pp. 1451-1458.
Lal et al., “Transcriptional response to hypoxia in human tumors”, Journal of the National Cancer Institute (Bethesda), vol. 93, No. 17, Sep. 5, 2001, pp. 1337-1343.
Wang et al., “Gene selection for microarray data analysis using principal component analysis”, Statistics in Medicine, vol. 24, No. 13, Jul. 2005, pp. 2069-2087.
Maokuan et al.“, Unlabeled data classification via support vector machines and k-means clustering”, Computer Graphics, Imaging and Visualization, 2004, CGIV 2004, Proceedings International Conference on Penang, Malaysia, Jul. 26-29, 2004, IEEE, Piscataway, NJ Jul. 26, 2004, pp. 183-186.
Ataman et al., “Learning to rank by maximizing AUC with linear programming”, IJCNN '06, International Joint Conference on Neural Networks, IEEE, Piscataway, NJ, 2006, pp. 123-129.
Starmans et al., “Proliferation and ‘invasiveness’ gene-expression signatures predict survival of surgically treated non-small-cell lung cancer: D6-03”, Journal of Thoracic Oncology, Suppl. 4, vol. 2, No. 8, Aug. 2007, p. S407.
Rosenwald et al., “The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma”, Cancer Cell, vol. 3, No. 2, Feb. 1, 2003, pp. 185-197.
Whitfield et al., “Common markers of proliferation”, Nature Reviews, Cancer Feb. 2006, vol. 6, No. 2, pp. 99-106.
Sotiriou et al., “Comprehensive molecular analysis of several prognostic signatures using molecular indices related to hallmarks of breast cancer: proliferation index appears to be the most significant component of all signatures”, Breast Cancer Research and Treatment, vol. 100, No. Suppl. 1, 2006, p. S86.
Desmedt et al., “Proliferation—The most prominent predictor of clinical outcome in breast cancer”, Cell Cycle, vol. 5, No. 19, Aug. 1, 2006, pp. 2198-2202.
Rhodes et al., “Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression”, Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, DC, vol. 101, No. 25, Jun. 22, 2004, pp. 9309-9314.
International Search Report including Notification of Transmittal of the International Search Report, International Search Report, and Written Opinion of the International Searching Authority.
Smith, “Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I)”, Investigational Drugs Journal; Dec. 2003; vol. 6, No. 12, pp. 1173-1177.
Klein et al., “Statistics for Biology and Health—A Self-Learning Text”, Springer, Second Edition, 2003; pp. 45-82.
Bild, A.H., et al., “Linking Oncogenic Pathways with Therapeutic Opportunities”, Nat. Rev. Cancer, 2006; 6 (9): 735-41.
Fan, JB, et al., “Highly parallel genomic assays”, Nat Rev Genet 2006;7:632-44.
Quackenbush, J., “Microarray Analysis and Tumor Classification”, N. Eng. J. of Med., 2006; 354(23): 2463-72.
Han, Z, et al., “Signal transduction network motifs and biological memory”, J Theor Biol 2007;246:755-61.
Hood, L, et al., “Systems biology and new technologies enable predictive medicine”, Science 2004;306:640-3.
Chang, H.Y., et al., “Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities Between Tumors and Wounds”, PLoS Biol., 2004; 2(2):E7.
Chi, J.T., et al., “Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers”, PLoS Med., 2006; 3(3):E47.
Palsson, B., “The challenges of in silico biology”, Nat Biotechnol 2000;18:1147-50.
Perou, CM, et al., “Molecular portraits of human breast tumours”, Nature 2000;406:747-52.
Chang HY, et al., “Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival” Proc Natl Acad Sci U S A 2005;102(10):3738-43.
Seigneuric, R, et al., “Impact of supervised gene signatures of early hypoxia on patient survival”, Rad. Oncol 2007.
van de Vijver MJ, et al., “A gene-expression signature as a predictor of survival in breast cancer”, N Engl. J Med 2002; 347(25):1999-2009.
Semenza, GL., “Targeting HIF-1 for cancer therapy”, Nat Rev Cancer 2003;3:721-32.
Vogelstein, B., et al., “Surfing the p53 network”, Nature 2000;408:307-10.
West, M, et al., “Embracing the complexity of genomic data for personalized medicine”, Genome Res 2006;16:559-66.
Ramaswamy, S, et al., “Multiclass cancer diagnosis using tumor gene expression signatures”, Proc Natl Acad Sci U S A 2001;98:15149-54.
Wouters, BG., et al., “Targeting hypoxia tolerance in cancer”, Drug Resist Updat 2004;7:25-40.
I. Guyon, et al., “Gene selection for cancer classification using support vector machines”, Machine Learning 2002;46,1-3, 389-422.
M. Schmidt, et al., “Fast optimization methods for L1 regularization: A comparatve study and two new approaches” To be published in the ECML 2007 procedings (http://pages.cs.wisc.edu/˜gfung/GeneralL1/).
S. Agarwal, et al., “Leaning to Rank”, Procedings of the NIPS 2005 workshop. 2005.
G. Fung, et al., “Learning rankins via convex hull separations”, NIPS 18 2006.
R. Rosales, et al., “Learning sparse metrics via linear programming”, Procedings of the 2006 conference on Knowledge Discovery and Data Mining (KDD 2006). 2006.
Miller LD, et al., “An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival”, Proc Natl. Acad. Sci. U S A 2005; 102(38):13550-5.
Fung, G., et al., “Reducing a biomarkers list via mathematical programming: application to gene signatures to detect time-dependent hypoxia in cancer”.
Bussink, J., et al., “Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy”, Ra

Affiliated with

Also associated with

Rating

Gene signature of early hypoxia to predict patient survival does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene signature of early hypoxia to predict patient survival, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene signature of early hypoxia to predict patient survival will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2631855